Alexander Mark Schobel

Insider Reports History

Location
Warren, NJ
Signature
/s/ Lori Braender, as Attorney-In-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Alexander Mark Schobel:

Company Role Class Num Shares Value Price $ Report Date Ownership
Aquestive Therapeutics, Inc. Chief Innovation/Tech Officer Common Stock 984,476 $5,906,856 $6.00 15 Mar 2024 Direct
Aquestive Therapeutics, Inc. Chief Innovation/Tech Officer Performance Stock Units 50,000 09 Aug 2023 Direct
Aquestive Therapeutics, Inc. Chief Innovation/Tech Officer Non-Qualified Stock Option (right to buy) 41,250 07 Mar 2024 Direct

Insider Reports Filed by Alexander Mark Schobel

Symbol Company Period Transactions Value $ Form Type Role Filing Time
AQST Aquestive Therapeutics, Inc. 15 Mar 2024 1 -$300,000 4 Chief Innovation/Tech Officer 19 Mar 2024, 14:30
AQST Aquestive Therapeutics, Inc. 09 Mar 2024 1 -$47,068 4/A Chief Innovation/Tech Officer 02 Oct 2024, 14:16
AQST Aquestive Therapeutics, Inc. 08 Mar 2024 2 -$158,453 4 Chief Innovation/Tech Officer 12 Mar 2024, 13:45
AQST Aquestive Therapeutics, Inc. 07 Mar 2024 2 $0 4 Chief Innovation/Tech Officer 11 Mar 2024, 10:36
AQST Aquestive Therapeutics, Inc. 09 Aug 2023 1 $0 4 Chief Innovation/Tech Officer 09 Aug 2023, 16:30
AQST Aquestive Therapeutics, Inc. 05 May 2023 1 $0 4 Chief Innovation/Tech Officer 05 May 2023, 16:00
AQST Aquestive Therapeutics, Inc. 09 Mar 2023 1 $0 4 Chief Innovation/Tech Officer 09 Mar 2023, 14:07
AQST Aquestive Therapeutics, Inc. 04 Nov 2022 1 $0 4 Chief Innovation/Tech Officer 08 Nov 2022, 09:22
AQST Aquestive Therapeutics, Inc. 08 Jun 2022 2 +$49,999 4 Chief Innovation/Tech Officer 10 Jun 2022, 17:26
AQST Aquestive Therapeutics, Inc. 10 Mar 2022 1 $0 4 Chief Innovation/Tech Officer 14 Mar 2022, 11:25